InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the detailed record of transactions filed by de Craecker Francoise. Officer active across 1 company, notably X4 Pharmaceuticals, Inc. Aggregated, 3 disclosures have been published. History available since 6 June 2022. The latest transaction was filed on 10 June 2024 (Attribution). Regulator: SEC (Form 4). All data is openly available.
3 of 3 declarations